首页> 外文OA文献 >Study of cell death and stages of leukocytes apoptosis in pulmonary tuberculosis patients with different antimycobacterial treatments
【2h】

Study of cell death and stages of leukocytes apoptosis in pulmonary tuberculosis patients with different antimycobacterial treatments

机译:肺结核治疗肺结核患者白细胞细胞凋亡细胞死亡及阶段研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of the study was to evaluate the condition of cytoplasmic membranes of leukocytes and to study their viability, to determine the varieties and stages of cell death of leukocytes in patients with pulmonary tuberculosis treated by different schemes of antimycobacterial treatment.Materials and methods. The study was performed on 30 patients with pulmonary tuberculosis: the 1st group – 12 patients treated by standard regimen with 1st line drugs; the 2nd group treated by individual regimen with 1st and 2nd line drugs.Results. The analysis of cytoplasmic membranes of leukocytes in the blood of patients from the 1st and the 2nd group showed that the proportion of live intact cells was 71.05±3.66%, that is lower by 20.75 % from the results of control group. In the 2nd group, the proportion of alive cells was lower by 12.9% than in the 1st group (р<0.05). In the same time, the proportion of leukocytes on the late of apoptosis/necrosis, that have deep damages of cell structure, was more than 10% higher than in the 1st group (р<0.05).Conclusions. A significant difference between the groups of patients in the proportion of absolutely alive leukocytes and cells on the late stage of apoptosis/necrosis can be a proof of higher activation of apoptosis process by individual treatment regimen that included 1st and 2nd line-drugs, compared with standard 1st line regimen. The obtained data allow us to recommend the study of influence of different anti-tuberculous drugs and regimens on apoptosis process of immune-competent cells, to evaluate the efficacy of pulmonary tuberculosis treatment.
机译:该研究的目的是评估白细胞细胞质膜的状况,并研究其活力,确定通过不同抗细管治疗不同方案治疗的肺结核患者白细胞的细胞死亡的品种和阶段。材料和方法。该研究是对30例肺结核患者进行:第1组 - 12例由标准方案与第一线药物治疗;由唯一的第1和第2线药物治疗的第二组。结果。 1ST和第二组患者血液中白细胞细胞质膜的分析表明,活性细胞的比例为71.05±3.66%,从对照组结果下降了20.75%。在第二组中,活细胞比例低12.9%,而不是第1组(р<0.05)。同时,白细胞的比例在晚期凋亡/坏死,细胞结构损害的深层损害,比第1组高出10%以上(р<0.05)。结论。在凋亡后期绝对活白细胞和细胞的比例的患者群体之间的显著差异/坏死可以通过个体化的治疗方案,其中包括第一和第二线药物的细胞凋亡过程的高活性的证明,相比标准第一线方案。所获得的数据允许我们建议研究不同抗结核药物和方案对免疫感应细胞凋亡过程的影响,以评估肺结核治疗的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号